Merck And Co Inc Drug Patent Portfolio

Merck And Co Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Merck And Co Inc News

Will Merck's Latest Medications and Development Pipeline Alleviate Concerns Over Keytruda's Loss of Exclusivity? - The Globe and Mail

16 Mar, 2026

Could Bristol Myers' Extensive Pipeline Be Crucial for Future Expansion? - TradingView

12 Mar, 2026

Keytruda and Padcev may form a formidable duo in the fight against cancer | PharmaVoice

11 Mar, 2026

FACT SHEET: Trump Visits Cincinnati to Discuss Drug Price Reductions Following Support for...

11 Mar, 2026

See More